106 related articles for article (PubMed ID: 31631753)
1. Cyclin D1 and PSA act as good prognostic and clinicopathological indicators for breast cancer.
Holah NS; Hemida AS
J Immunoassay Immunochem; 2020; 41(1):28-44. PubMed ID: 31631753
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 overexpression associates with favourable prognostic factors in invasive breast carcinoma.
El-Hafez AA; El Aaty Shawky A; Hasan B
Cancer Biomark; 2012; 12(4):149-54. PubMed ID: 23568005
[TBL] [Abstract][Full Text] [Related]
3. Molecular markers for predicting prostate cancer stage and survival.
Dunsmuir WD; Gillett CE; Meyer LC; Young MP; Corbishley C; Eeles RA; Kirby RS
BJU Int; 2000 Nov; 86(7):869-78. PubMed ID: 11069416
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype.
Mylona E; Tzelepis K; Theohari I; Giannopoulou I; Papadimitriou C; Nakopoulou L
Histopathology; 2013 Feb; 62(3):472-80. PubMed ID: 23163571
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters.
Ravikumar G; Ananthamurthy A
J Cancer Res Ther; 2014; 10(3):671-5. PubMed ID: 25313758
[TBL] [Abstract][Full Text] [Related]
6. Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer.
Villegas SL; Darb-Esfahani S; von Minckwitz G; Huober J; Weber K; Marmé F; Furlanetto J; Schem C; Pfitzner BM; Lederer B; Engels K; Kümmel S; Müller V; Mehta K; Denkert C; Loibl S
Breast Cancer Res Treat; 2018 Feb; 168(1):179-187. PubMed ID: 29177689
[TBL] [Abstract][Full Text] [Related]
7. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
8. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance.
Carlos de Vicente J; Herrero-Zapatero A; Fresno MF; López-Arranz JS
Oral Oncol; 2002 Apr; 38(3):301-8. PubMed ID: 11978554
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 expression as a prognostic factor in advanced hypopharyngeal carcinoma.
Nishimura G; Tsukuda M; Zhou LX; Furukawa S; Baba Y
J Laryngol Otol; 1998 Jun; 112(6):552-5. PubMed ID: 9764295
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy.
Pelosio P; Barbareschi M; Bonoldi E; Marchetti A; Verderio P; Caffo O; Bevilacqua P; Boracchi P; Buttitta F; Barbazza R; Dalla Palma P; Gasparini G
Ann Oncol; 1996 Sep; 7(7):695-703. PubMed ID: 8905027
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of Pin-1 and VEGF-C expression in breast infiltrating duct carcinoma.
Kim BC; Han SI; Lim SC
Oncol Rep; 2009 Dec; 22(6):1381-90. PubMed ID: 19885590
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
[TBL] [Abstract][Full Text] [Related]
15. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma.
Lim SC
Oncol Rep; 2003; 10(5):1241-9. PubMed ID: 12883688
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of cyclin D1 in invasive breast carcinoma and its correlation with clinicopathological parameters.
Lengare PV; Sinai Khandeparkar SG; Joshi AR; Gogate BP; Solanke SG; Gore SH
Indian J Pathol Microbiol; 2020; 63(3):376-381. PubMed ID: 32769325
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of cyclin D1 in breast cancer.
Bilalović N; Vranić S; Basić H; Tatarević A; Selak I
Croat Med J; 2005 Jun; 46(3):382-8. PubMed ID: 15861516
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of tumor cyclin D1 expression in oral cancer.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ayén Á; Ruiz-Ávila I; Bravo M; Gil-Montoya JA
Arch Oral Biol; 2019 Mar; 99():177-182. PubMed ID: 30721793
[TBL] [Abstract][Full Text] [Related]
19. Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information.
Tobin NP; Lundgren KL; Conway C; Anagnostaki L; Costello S; Landberg G
Hum Pathol; 2012 Nov; 43(11):2053-61. PubMed ID: 22647349
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.
Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY
Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
